Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ARVN | ARVINAS, INC. | Director | $810K | May 29, 2024 | ||
ATXS | Astria Therapeutics, Inc. | Director | Apr 8, 2024 | |||
CALA | Calithera Biosciences, Inc. | Director | Jun 1, 2022 | |||
SANA | Sana Biotechnology, Inc. | EVP, Head of Development & CMO | Mar 3, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|